Online GLP-1 Programs in Arkansas

Insurance

Does Arkansas Medicaid cover GLP-1s?

Arkansas Medicaid covers GLP-1s for type 2 diabetes but not for weight loss (Arkansas Center for Health Improvement, 2024). A 2025 bill, HB 1332, would have required Medicaid and insurers to cover weight-loss GLP-1s, but it died in a Senate committee at the end of the session. For weight management specifically, there is no Medicaid path.

Online Access

Getting a GLP-1 online in Arkansas

GLP-1s are not controlled substances, so Arkansas allows them to be prescribed via telehealth. The state requires a real-time audio-and-video evaluation to establish the relationship, not a questionnaire alone, and the prescriber must hold an Arkansas license. Online programs can serve residents statewide.

Compounding

Compounded semaglutide & tirzepatide in Arkansas

Routine compounding of semaglutide and tirzepatide ended after the FDA resolved the shortages in early 2025 (FDA, 2025). Arkansas adds no special carve-out beyond the federal 503A/503B framework, so compounding is limited to documented, patient-specific clinical need.

Demand

Where GLP-1 demand is highest in Arkansas

Arkansas has the fifth-highest adult obesity rate in the nation, around 39%, and a diabetes rate near 15% (CDC BRFSS via America's Health Rankings and ACHI, 2024). Demand is high across Little Rock and Northwest Arkansas around Fayetteville. The state's heavy burden sits against no Medicaid weight-loss coverage and a failed 2025 coverage bill, so most access runs through cash-pay and telehealth.

Questions

Arkansas GLP-1 FAQ

Compound Guides

The GLP-1s behind these programs

Sources

How we sourced this page

Coverage, prevalence, and policy figures are drawn from primary and authoritative sources, last reviewed June 2026.